164 related articles for article (PubMed ID: 38540708)
1. Senescence Promotes the Recovery of Stemness among Cancer Cells via Reprograming.
Wang D; Liu L
Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540708
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin-induced senescence promotes stemness and tumorigenicity in EpCAM-/CD133- nonstem cell population in hepatocellular carcinoma cell line, HuH-7.
Karabicici M; Alptekin S; Fırtına Karagonlar Z; Erdal E
Mol Oncol; 2021 Aug; 15(8):2185-2202. PubMed ID: 33524223
[TBL] [Abstract][Full Text] [Related]
3. Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.
Walcher L; Kistenmacher AK; Suo H; Kitte R; Dluczek S; Strauß A; Blaudszun AR; Yevsa T; Fricke S; Kossatz-Boehlert U
Front Immunol; 2020; 11():1280. PubMed ID: 32849491
[TBL] [Abstract][Full Text] [Related]
4. Oncogene-induced senescence: a double edged sword in cancer.
Liu XL; Ding J; Meng LH
Acta Pharmacol Sin; 2018 Oct; 39(10):1553-1558. PubMed ID: 29620049
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of cancer stem cell senescence: Current understanding and future perspectives.
Zhang DY; Monteiro MJ; Liu JP; Gu WY
Clin Exp Pharmacol Physiol; 2021 Sep; 48(9):1185-1202. PubMed ID: 34046925
[TBL] [Abstract][Full Text] [Related]
6. Senescence-Induced Chemoresistance in Triple Negative Breast Cancer and Evolution-Based Treatment Strategies.
Chakrabarty A; Chakraborty S; Bhattacharya R; Chowdhury G
Front Oncol; 2021; 11():674354. PubMed ID: 34249714
[TBL] [Abstract][Full Text] [Related]
7. Senescence-associated reprogramming promotes cancer stemness.
Milanovic M; Fan DNY; Belenki D; Däbritz JHM; Zhao Z; Yu Y; Dörr JR; Dimitrova L; Lenze D; Monteiro Barbosa IA; Mendoza-Parra MA; Kanashova T; Metzner M; Pardon K; Reimann M; Trumpp A; Dörken B; Zuber J; Gronemeyer H; Hummel M; Dittmar G; Lee S; Schmitt CA
Nature; 2018 Jan; 553(7686):96-100. PubMed ID: 29258294
[TBL] [Abstract][Full Text] [Related]
8. MLL1 is essential for the senescence-associated secretory phenotype.
Capell BC; Drake AM; Zhu J; Shah PP; Dou Z; Dorsey J; Simola DF; Donahue G; Sammons M; Rai TS; Natale C; Ridky TW; Adams PD; Berger SL
Genes Dev; 2016 Feb; 30(3):321-36. PubMed ID: 26833731
[TBL] [Abstract][Full Text] [Related]
9. Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line.
Ortiz-Montero P; Londoño-Vallejo A; Vernot JP
Cell Commun Signal; 2017 May; 15(1):17. PubMed ID: 28472950
[TBL] [Abstract][Full Text] [Related]
10. A complex secretory program orchestrated by the inflammasome controls paracrine senescence.
Acosta JC; Banito A; Wuestefeld T; Georgilis A; Janich P; Morton JP; Athineos D; Kang TW; Lasitschka F; Andrulis M; Pascual G; Morris KJ; Khan S; Jin H; Dharmalingam G; Snijders AP; Carroll T; Capper D; Pritchard C; Inman GJ; Longerich T; Sansom OJ; Benitah SA; Zender L; Gil J
Nat Cell Biol; 2013 Aug; 15(8):978-90. PubMed ID: 23770676
[TBL] [Abstract][Full Text] [Related]
11. Regulation of senescence and the SASP by the transcription factor C/EBPβ.
Salotti J; Johnson PF
Exp Gerontol; 2019 Dec; 128():110752. PubMed ID: 31648009
[TBL] [Abstract][Full Text] [Related]
12. Oncogene-induced senescence: From biology to therapy.
Zhu H; Blake S; Kusuma FK; Pearson RB; Kang J; Chan KT
Mech Ageing Dev; 2020 Apr; 187():111229. PubMed ID: 32171687
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase D1 is essential for Ras-induced senescence and tumor suppression by regulating senescence-associated inflammation.
Wang P; Han L; Shen H; Wang P; Lv C; Zhao G; Niu J; Xue L; Wang QJ; Tong T; Chen J
Proc Natl Acad Sci U S A; 2014 May; 111(21):7683-8. PubMed ID: 24828530
[TBL] [Abstract][Full Text] [Related]
14. The Senescence-associated Secretory Phenotype Mediates Oncogene-induced Senescence in Pediatric Pilocytic Astrocytoma.
Buhl JL; Selt F; Hielscher T; Guiho R; Ecker J; Sahm F; Ridinger J; Riehl D; Usta D; Ismer B; Sommerkamp AC; Martinez-Barbera JP; Wefers AK; Remke M; Picard D; Pusch S; Gronych J; Oehme I; van Tilburg CM; Kool M; Kuhn D; Capper D; von Deimling A; Schuhmann MU; Herold-Mende C; Korshunov A; Brummer T; Pfister SM; Jones DTW; Witt O; Milde T
Clin Cancer Res; 2019 Mar; 25(6):1851-1866. PubMed ID: 30530705
[TBL] [Abstract][Full Text] [Related]
15. Quantifying Senescence-Associated Phenotypes in Primary Multipotent Mesenchymal Stromal Cell Cultures.
Nadeau S; Cheng A; Colmegna I; Rodier F
Methods Mol Biol; 2019; 2045():93-105. PubMed ID: 31020633
[TBL] [Abstract][Full Text] [Related]
16. The Jekyll and Hyde of Cellular Senescence in Cancer.
Demirci D; Dayanc B; Mazi FA; Senturk S
Cells; 2021 Jan; 10(2):. PubMed ID: 33494247
[TBL] [Abstract][Full Text] [Related]
17. Punicalagin induces senescent growth arrest in human papillary thyroid carcinoma BCPAP cells via NF-κB signaling pathway.
Cheng X; Yao X; Xu S; Pan J; Yu H; Bao J; Guan H; Lu R; Zhang L
Biomed Pharmacother; 2018 Jul; 103():490-498. PubMed ID: 29677534
[TBL] [Abstract][Full Text] [Related]
18. The Immortal Senescence.
Bianchi-Smiraglia A; Lipchick BC; Nikiforov MA
Methods Mol Biol; 2017; 1534():1-15. PubMed ID: 27812863
[TBL] [Abstract][Full Text] [Related]
19. The senescence-associated secretory phenotype (SASP) from mesenchymal stromal cells impairs growth of immortalized prostate cells but has no effect on metastatic prostatic cancer cells.
Alessio N; Aprile D; Squillaro T; Di Bernardo G; Finicelli M; Melone MA; Peluso G; Galderisi U
Aging (Albany NY); 2019 Aug; 11(15):5817-5828. PubMed ID: 31412320
[TBL] [Abstract][Full Text] [Related]
20. The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration.
Ritschka B; Storer M; Mas A; Heinzmann F; Ortells MC; Morton JP; Sansom OJ; Zender L; Keyes WM
Genes Dev; 2017 Jan; 31(2):172-183. PubMed ID: 28143833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
